These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28341360)

  • 1. Use of mexiletine in therapy-refractory recurrent ventricular tachycardia storm.
    Szonyi MD; Pap R; Vamos M
    Herzschrittmacherther Elektrophysiol; 2023 Dec; 34(4):326-329. PubMed ID: 37917362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular tachycardia and sudden cardiac death.
    Koplan BA; Stevenson WG
    Mayo Clin Proc; 2009 Mar; 84(3):289-97. PubMed ID: 19252119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for mexiletine in the new ESC guidelines and beyond.
    Vamos M; Zsigmond EJ; Hohnloser SH
    Expert Opin Pharmacother; 2023; 24(12):1403-1407. PubMed ID: 37306465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias.
    Alhourani N; Wolfes J; Könemann H; Ellermann C; Frommeyer G; Güner F; Lange PS; Reinke F; Köbe J; Eckardt L
    Clin Res Cardiol; 2024 Jun; 113(6):791-800. PubMed ID: 38353682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of empagliflozin on ventricular arrhythmias in heart failure patients with an implantable cardioverter-defibrillator: a double-blind randomized controlled trial.
    Abedi F; Mohammadpour AH; Ghavami V; Heidari-Bakavoli A; Jomezadeh V; Tayyebi M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; ():. PubMed ID: 39002088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a Medicare Mandate for Shared Decision-Making With Cardiac Device Utilization.
    Rager JB; Hou H; Caverly T; Thompson MP
    JAMA Intern Med; 2024 Apr; 184(4):439-440. PubMed ID: 38372991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranolazine: safe and effective in a patient with hypertensive cardiomyopathy and multiple episodes of electrical storm.
    Margos P; Margos N; Mokadem N; Patsiotis I; Kranidis A
    Clin Case Rep; 2017 Jul; 5(7):1170-1175. PubMed ID: 28680620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranolazine therapy in drug-refractory ventricular arrhythmias.
    Curnis A; Salghetti F; Cerini M; Vizzardi E; Sciatti E; Vassanelli F; Villa C; Inama L; Raweh A; Giacopelli D; Bontempi L
    J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):534-538. PubMed ID: 28368882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis.
    De Vecchis R; Ariano C; Giasi A; Cioppa C
    Minerva Cardioangiol; 2018 Jun; 66(3):349-359. PubMed ID: 28497941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.
    Santangeli P; Rame JE; Birati EY; Marchlinski FE
    J Am Coll Cardiol; 2017 Apr; 69(14):1842-1860. PubMed ID: 28385314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinus Bradycardia in Habitual Cocaine Users.
    Franklin SM; Thihalolipavan S; Fontaine JM
    Am J Cardiol; 2017 May; 119(10):1611-1615. PubMed ID: 28341362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias.
    Ganesh A; Qadri YJ; Boortz-Marx RL; Al-Khatib SM; Harpole DH; Katz JN; Koontz JI; Mathew JP; Ray ND; Sun AY; Tong BC; Ulloa L; Piccini JP; Fudim M
    Curr Hypertens Rep; 2020 Oct; 22(12):100. PubMed ID: 33097982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.
    Pokorney SD; Mi X; Hammill BG; Allen LaPointe NM; Curtis LH; Al-Khatib SM
    Am J Cardiol; 2017 May; 119(9):1401-1406. PubMed ID: 28341360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
    Bunch TJ; Mahapatra S; Murdock D; Molden J; Weiss JP; May HT; Bair TL; Mader KM; Crandall BG; Day JD; Osborn JS; Muhlestein JB; Lappe DL; Anderson JL
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1600-6. PubMed ID: 21895727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
    Ferrari R; Cinca J; Marber M
    Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy.
    Droogan C; Patel C; Yan GX; Kowey PR
    Heart Fail Clin; 2011 Apr; 7(2):195-205, viii. PubMed ID: 21439498
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.